BioSpace News Archive

Biotech Bay

Are Life Science Companies Falling Behind Tech Companies?

Tech companies have been making significant forays into the life sciences and a new report suggests that life science companies are in danger of falling behind their tech brethren..

March 13, 2018
·
2 min read
·
Mark Terry
Drug Development

Proteostasis Therapeutics Snags Breakthrough Designation

The U.S. Food and Drug Administration granted Proteostasis Therapeutics’ investigational cystic fibrosis add-on therapy the Breakthrough Therapy Designation.

March 13, 2018
·
2 min read
·
Alex Keown
Drug Development

Aeglea BioTherapeutics Updates Phase I/II Trial Data

Aeglea BioTherapeutics announced new repeat dose data from its Phase I/II trial of AEB1102 (pegzilarginase) in patients with Arginase 1 Deficiency.

March 13, 2018
·
3 min read
·
Mark Terry
Drug Development

Protalix BioTherapeutics Treatment for Ulcerative Colitis Shows Positive Data

Protalix BioTherapeutics believes it’s on the right track in developing an oral medicine for ulcerative colitis that could potentially replace current TNF-inhibitor therapies that are administered via injection or infusion.

March 13, 2018
·
2 min read
·
Alex Keown
Drug Development

AbbVie’s Elagolix Dazzles in Phase III Trial

AbbVie and Neurocrine Biosciences announced that its Phase III ELARIS UF-II trial of elagolix for uterine fibroids met its primary endpoint.

March 13, 2018
·
2 min read
·
Mark Terry
Drug Development

FDA Grants Merck’s Keytruda Priority Review for Cervical Cancer

The FDA accepted Merck & Co.’s supplemental Biologics License Application and granted Priority Review for Keytruda in advanced cervical cancer.

March 13, 2018
·
3 min read
·
Mark Terry
What’s wrong with being busy? How to work less and accomplish more

What’s wrong with being busy? According to career experts, psychologists and other healthcare providers, and industry leaders, a whole a lot.

March 13, 2018
·
7 min read
Drug Development

FDA Halts Advaxis Study Following Patient Death

The FDA placed a hold on Advaxis’ Phase I/II trial following the death of a patient.

March 13, 2018
·
2 min read
·
Alex Keown
Business

Centene And RxAdvance Establish Transformative Partnership To Create Next Generation Pharmacy Management Solution

Centene Corporation (NYSE: CNC) announced today that it has made an initial investment in RxAdvance.

March 13, 2018
·
1 min read
Biotech Beach

Global 1 Medical Bundled Payment System Disrupting U.S. Healthcare One Bill At A Time

Global 1 today announced it has expanded its medical bundled payment system to more than 85 outpatient surgery centers with a growing network of more than 650 physicians.

March 13, 2018
·
2 min read